Objective: To determine the clinical effectiveness and safety of a compounded sustained-release formulation of buprenorphine, compared with effects of regular buprenorphine, for postoperative analgesia in rabbits.
Design: Blinded randomized controlled clinical trial.
Animals: 24 purpose-bred adult male New Zealand White rabbits.